Cargando…
Diabetic complications and prospective immunotherapy
The incidence of Diabetes Mellitus is increasing globally. Individuals who have been burdened with diabetes for many years often develop complications as a result of hyperglycemia. More and more research is being conducted highlighting inflammation as an important factor in disease progression. In a...
Autores principales: | Reynolds, Lewis, Luo, Zhengkang, Singh, Kailash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360133/ https://www.ncbi.nlm.nih.gov/pubmed/37483613 http://dx.doi.org/10.3389/fimmu.2023.1219598 |
Ejemplares similares
-
Interleukin-35 Prevents the Elevation of the M1/M2 Ratio of Macrophages in Experimental Type 1 Diabetes
por: Luo, Zhengkang, et al.
Publicado: (2022) -
Recent Developments in Cellular Immunotherapy for HSCT-Associated Complications
por: Reis, Monica, et al.
Publicado: (2016) -
Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects
por: Singh, Om Prakash, et al.
Publicado: (2014) -
Clinical cancer immunotherapy: Current progress and prospects
por: Liu, Chenglong, et al.
Publicado: (2022) -
Kinetics of immune cell responses in the multiple low‐dose streptozotocin mouse model of type 1 diabetes
por: Luo, Zhengkang, et al.
Publicado: (2019)